PLIANT THERAPEUTICS INC
PLRXNASDAQ🏆 #4305 by market capEarnings Nov 4US Equity
$1.08▲ $0.00 (+0.00%)
🌙 After hours$1.08▲ 0.00%Regular close · extended-hours price shownTrack PLRX
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d▼ 3.6%
14d▼ 0.9%
30d▼ 2.3%
ytd▼ 10.7%
1y▼ 26.8%
🏦Market Cap
$67M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
13.3x
Elevated
Otter Score
48
Weak
PLIANT THERAPEUTICS INC
PLRXAnalyst Ratings
Price
$1.08
Total
16
Raised
0
Lowered
3
Avg PT
$25.86
H / L
$48 / $2
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Canaccord Genuity | Reiterated | Hold | 2026-03-13 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-03-12 | $3.00 | +177.80% |
RBC Capital | Reiterated | Sector Perform | 2025-11-07 | $45.00 | +4066.70% |
JP Morgan | Downgraded | Neutral → Underweight | 2025-10-10 | $42.00 | +3788.90% |
HC Wainwright & Co. | Reiterated | Neutral | 2025-03-18 | — | — |
Wells Fargo | Reiterated | Equal Weight | 2025-03-04 | — | — |
Needham | Downgraded | Buy → Hold | 2025-03-04 | — | — |
Citigroup | Reiterated | Neutral | 2025-03-04 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-03-03 | $2.00 | +85.20% |
Oppenheimer | Reiterated | Outperform | 2024-08-08 | $48.00 | +4344.40% |
Cantor Fitzgerald | Reiterated | Overweight | 2023-08-22 | — | — |
Baird | Reiterated | Outperform | 2023-04-13 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-24 | — | — |
Stifel | Reiterated | Buy | 2022-12-14 | — | — |
BTIG | Reiterated | Buy | 2021-04-20 | — | — |
Cowen & Co. | Reiterated | Outperform | 2020-06-29 | — | — |
Institution
Canaccord Genuity
Reiterated · Hold · 2026-03-13
—
—
Piper Sandler
Reiterated · Overweight · 2026-03-12
$3.00
+177.80%
RBC Capital
Reiterated · Sector Perform · 2025-11-07
$45.00
+4066.70%
JP Morgan
Downgraded · Neutral → Underweight · 2025-10-10
$42.00
+3788.90%
HC Wainwright & Co.
Reiterated · Neutral · 2025-03-18
—
—
Wells Fargo
Reiterated · Equal Weight · 2025-03-04
—
—
Needham
Downgraded · Buy → Hold · 2025-03-04
—
—
Citigroup
Reiterated · Neutral · 2025-03-04
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-03-03
$2.00
+85.20%
Oppenheimer
Reiterated · Outperform · 2024-08-08
$48.00
+4344.40%
Cantor Fitzgerald
Reiterated · Overweight · 2023-08-22
—
—
Baird
Reiterated · Outperform · 2023-04-13
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-24
—
—
Stifel
Reiterated · Buy · 2022-12-14
—
—
BTIG
Reiterated · Buy · 2021-04-20
—
—
Cowen & Co.
Reiterated · Outperform · 2020-06-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space